Skip to content

The effect of Hyoscine -suppository on labor

The effect of Hyoscine - N - Butyl Bromide suppository on labor pain and process in nuliparous women

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138804282204N1
Enrollment
130
Registered
2010-02-10
Start date
2009-07-03
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Labor pain. Condition 2: Labor process. spontaneus vertex delivery spontaneus vertex delivery

Interventions

Intervention 1: hyoscine suppositiry 20 mg single dose. Intervention 2: placebo suppository.
hyoscine suppositiry 20 mg single dose

Sponsors

Research vice chancellor of Ahwaz jondishapour university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1.age 18-35 2. gestational age: 37-42 by LMP or under 26 weeks by sonography 3.single fetus 4. cephalic presentation 5.cervical dilatation= 3-4 cm 6. Cervical effacement = 30-60% 7.bishop score>7 8.spontaneous uterine contractions in the form of 3 contractions with 40 minutes duration per 10 min 9.minimum education= grade 5 at primary school. Exclusion criteria : 1.vaginal bleeding 2.abnormal fetal heart rate 3.neonatal body weight4000 gr 4.fetal abnormality or death 5.high risk pregnancy 6.history of uterine surgery 7.mother's tachycardia 8.history of medical disorder in mother 9.oxytocin infusion in labor stages 10.use of Narcotic or anodyne drug or other pain reliever methods 11.delivery in 2 hours from onset of study 12.Athletic mothers 13.addict mothers 14.Corporation in pre-labor education classes

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Labor pain. Timepoint: each 0.5 h. Method of measurement: visual analog scale.;Cervical dilatation. Timepoint: each 1 h. Method of measurement: examination.;Cervical effacement. Timepoint: each 1 h. Method of measurement: examination.;Labor active phase duration. Timepoint: at the end. Method of measurement: observation.;Labor second stage duration. Timepoint: at the end. Method of measurement: observation.;Delivery type. Timepoint: at the end. Method of measurement: observation.

Secondary

MeasureTime frame
Neonatal Apgar score. Timepoint: at 1st and 5th minutes. Method of measurement: Examination & Ovservation.;Maternal blood pressure. Timepoint: each 0.5 h. Method of measurement: examination.;Fetal heart rate. Timepoint: each 0.5 h. Method of measurement: examination.;Maternal pulse rate. Timepoint: each 0.5 h. Method of measurement: examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSomaye Makvandi

Ahwaz jondishapour university of medical scienses

s-makvandi@ajums.ac.ir ; somayemakvandi@gmail.com ; mardookh2000@yahoo.com

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026